Secondaries announced 6.9.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Ignyta, Inc.
Symbol: RXDX
Price: Last trade $18.08
Trade Date: 6/10
Shares: 4.1 million
Underwriter(s) Credit Suisse, Jefferies, Leerink Partners, Piper Jaffray
Co Manager(s) Cantor Fitzgerald, Ladenburg Thalmann
Rating=Subscription Needed

Company: Heron Therapeutics
Symbol: HRTX
Price: Last trade $26.07
Trade Date: 6/10
Shares: 3.83 million
Underwriter(s) Jefferies, Leerink Partners, Cowen & Co.
Rating=Subscription Needed

Company: Gulfport Energy
Symbol: GPOR
Price: Last trade $45.37
Trade Date: 6/10
Shares: 10 million
Underwriter(s) Credit Suisse
Rating=Subscription Needed

Company: Cynapsus Therapeutics
Symbol: CYNA
Price: Last trade $14.18
Description: Currently listed on the Toronto Stock Exchange under the symbol ‘CTH’.
Trade Date: 6/18
Shares: 4.5 million
Underwriter(s) BofA Merrill Lynch, Nomura
Co Manager(s) Noble Life Science Partners
Rating=Subscription Needed

Company: Scorpio Bulkers
Symbol: SALT
Price: Last trade $2.17
Trade Date: 6/11
Shares: 92 million
Underwriter(s) Deutsche Bank Securities, Clarksons Platou Securities AS, Evercore ISI, Stifel
Co Manager(s) ABN AMRO, Credit Agricole CIB, Clarksons Platou Securities
Rating=Subscription Needed

Company: Chimerix, Inc.
Symbol: CMRX
Price: Last trade $41.66
Trade Date: 6/11
Shares: 3.6 million
Underwriter(s) Morgan Stanley, J.P. Morgan
Rating=Subscription Needed

Company: New Residential Investment Corp.
Symbol: NRZ
Price: Last trade $16.63
Trade Date: 6/10
Shares: 31.5 million
Underwriter(s) BofA Merrill Lynch, Citigroup, J.P. Morgan
Rating=Subscription Needed